
CVS Health stock rated soft Buy as profits double and revenue grows 6.7% amid operational gains.
CVS Health Corporation's stock is rated a soft Buy due to improved profitability and valuation. The company reported a 6.7% increase in revenue to $206.5 billion and more than doubled its net income, driven by operational improvements in its segments...


